Prevalence and risk factors of sarcopenia in Chinese maintenance hemodialysis patients: a systematic review and meta-analysis

Author:

Dou jun-kai1,LI LI1,Yang shun-ying1,Zhang Ying1,Yang Liang1,Liu Huan1,Shi Xue-zhi1

Affiliation:

1. Lu'an Hospital of Anhui Medical University

Abstract

AbstractBackground:Patients with maintenance hemodialysis often suffer from sarcopenia, but there are differences in the prevalence and risk factors of sarcopenia in some studies. The purpose of this study was to estimate the prevalence and risk factors for sarcopenia in Chinese maintenance hemodialysis (MHD) patients.Methods:China National Knowledge Infrastructure, Wanfang, Chinese Biological Medical Database, PubMed, Web of Science, EMBASE and The Cochrane Library were searched through their inception to 11 April 2023. Cross-sectional, case-control and cohort studies published in the Chinese or English, and performed on prevalence and risk factors of sarcopenia among Chinese MHD patients. Two reviewers independently conducted data extraction and assessed the quality of the studies. The prevalence of sarcopenia and the ORs of potential associated factors were synthesized by Stata V.14.0 software.ResultTwenty-eight studies involving 6123 MHD patients were included. The overall pooled prevalence of sarcopenia in Chinese MHD patients was 29.0% (95% CI 25.0% to 32.0%). Age, BMI, dialysis duration, hs-CRP, MQSGA, upper arm circumference and gender were significantly related to sarcopenia, with the OR of 1.17 95%CI (1.10 to 1.24), 0.67 95%CI(0.56 to 0.81), 1.16 95%CI(1.08 to 1.25), 1.35 95%CI(1.14 to 1.58), 1.75 95%CI(1.37 to 2.23), 0.72 95%CI(0.65 to 0.79) and 2.63 95%CI(1.44 to 4.83), respectively.ConclusionThe overall sarcopenia among Chinese MHD patients is high. Age, dialysis duration, hs-CRP, MQSGA score, and female are possible risk factors for sarcopenia.

Publisher

Research Square Platform LLC

Reference62 articles.

1. Worldwide access to treatment for end-stage kidney disease: a systematic review;Liyanage T;Lancet,2015

2. Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report;Yang C;Kidney Int,2020

3. Estimation of Prevalence of Kidney Disease Treated With Dialysis in China: A Study of Insurance Claims Data;Yang C;Am J Kidney Dis,2021

4. Importance of Considering Malnutrition and Sarcopenia in Order to Improve the QOL of Elderly Hemodialysis Patients in Japan in the Era of 100-Year Life;Inaba M;Nutrients,2021

5. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People;Cruz-Jentoft AJ;Age Ageing,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3